S&Co Has Raised Range Resources Com (RRC) Position; Atara Biotherapeutics (ATRA)’s Sentiment Is 1.54

February 20, 2018 - By Michael Collier

S&Co Inc increased Range Resources Corp Com (RRC) stake by 151.89% reported in 2017Q3 SEC filing. S&Co Inc acquired 152,474 shares as Range Resources Corp Com (RRC)’s stock declined 18.29%. The S&Co Inc holds 252,856 shares with $4.95M value, up from 100,382 last quarter. Range Resources Corp Com now has $3.24 billion valuation. The stock decreased 2.57% or $0.35 during the last trading session, reaching $13.28. About 7.50M shares traded. Range Resources Corporation (NYSE:RRC) has declined 36.05% since February 20, 2017 and is downtrending. It has underperformed by 52.75% the S&P500.

Atara Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for patients with severe and life-threatening diseases in the United States. The company has market cap of $1.71 billion. The Company’s clinical stage T-cell product candidates include ATA129 that focuses on Phase III clinical trials for the treatment of rituximab-refractory epstein-barr virus associated post-transplant lymphoproliferative disorder after hematopoietic cell transplant and solid organ transplant; ATA188, which is in Phase I clinical trial for the treatment of multiple sclerosis; ATA520, a Phase I clinical trial product targeting cancers expressing the antigen Wilms tumor 1; and ATA230, which is Phase III clinical trials for refractory cytomegalovirus. It currently has negative earnings. The firm is also developing a next generation of allogeneic T-cell product candidates utilizing a technology to selectively enhance a T-cellÂ’s ability to target specific viral proteins implicated in disease.

Investors sentiment is 1.35 in 2017 Q3. Its the same as in 2017Q2. It is flat, as 55 investors sold RRC shares while 102 reduced holdings. only 52 funds opened positions while 160 raised stakes. 248.08 million shares or 7.58% more from 230.61 million shares in 2017Q2 were reported. Citigroup stated it has 0% in Range Resources Corporation (NYSE:RRC). Chevy Chase has 2.26M shares for 0.2% of their portfolio. Blue Ridge Capital Limited Liability Co reported 1.85 million shares or 0.65% of all its holdings. Edge Wealth Limited Liability Corp, a New York-based fund reported 34,058 shares. Mason Street Advisors Ltd owns 0.02% invested in Range Resources Corporation (NYSE:RRC) for 31,346 shares. Wealthfront has 0.01% invested in Range Resources Corporation (NYSE:RRC). Adams Natural Resource Fund has invested 0.97% of its portfolio in Range Resources Corporation (NYSE:RRC). Geode Mgmt Limited Co stated it has 0.02% in Range Resources Corporation (NYSE:RRC). Guardian Life Of America owns 0% invested in Range Resources Corporation (NYSE:RRC) for 510 shares. Stephens Incorporated Ar invested 0.01% of its portfolio in Range Resources Corporation (NYSE:RRC). Royal Bank Of Canada holds 0.01% of its portfolio in Range Resources Corporation (NYSE:RRC) for 1.04 million shares. Sg Americas Ltd Liability owns 14,170 shares or 0% of their US portfolio. Farmers & Merchants Investments holds 0% or 142 shares in its portfolio. Fifth Third Bancorp holds 178 shares. Nomura Incorporated holds 0% or 38,843 shares in its portfolio.

Since October 26, 2017, it had 1 buying transaction, and 3 insider sales for $228,453 activity. On Tuesday, January 30 the insider PALKO STEFFEN E bought $500,609. 2,897 shares valued at $46,533 were sold by DUB ANTHONY V on Thursday, December 14. 10,757 Range Resources Corporation (NYSE:RRC) shares with value of $176,678 were sold by MANNY ROGER S. The insider Poole David P sold $505,851.

Among 42 analysts covering Range Resources Corp. (NYSE:RRC), 24 have Buy rating, 3 Sell and 15 Hold. Therefore 57% are positive. Range Resources Corp. had 139 analyst reports since July 21, 2015 according to SRatingsIntel. The rating was upgraded by Zacks to “Sell” on Friday, August 28. Piper Jaffray maintained the stock with “Buy” rating in Thursday, October 19 report. The rating was upgraded by UBS to “Buy” on Thursday, March 30. RBC Capital Markets upgraded Range Resources Corporation (NYSE:RRC) on Thursday, November 12 to “Outperform” rating. Jefferies maintained Range Resources Corporation (NYSE:RRC) rating on Tuesday, August 29. Jefferies has “Buy” rating and $36.0 target. The company was initiated on Wednesday, December 9 by JP Morgan. The stock of Range Resources Corporation (NYSE:RRC) earned “Buy” rating by Credit Suisse on Monday, December 11. On Sunday, August 20 the stock rating was maintained by Cowen & Co with “Buy”. The rating was maintained by BMO Capital Markets on Tuesday, October 10 with “Buy”. RBC Capital Markets maintained Range Resources Corporation (NYSE:RRC) rating on Monday, May 2. RBC Capital Markets has “Outperform” rating and $47 target.

Since January 1, 0001, it had 0 buys, and 14 insider sales for $5.79 million activity.

Analysts await Atara Biotherapeutics, Inc. (NASDAQ:ATRA) to report earnings on March, 8. They expect $-1.14 earnings per share, down 80.95% or $0.51 from last year’s $-0.63 per share. After $-1.02 actual earnings per share reported by Atara Biotherapeutics, Inc. for the previous quarter, Wall Street now forecasts 11.76% negative EPS growth.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: